genekor

1 February, 2024

‘Man at the Centre: Co-Creating the Context”

This year, World Cancer Day coincides with the date of the 8th Annual Conference of the Hellenic Cancer Federation (ELLOK): ‘Man at the Centre: Co-Creating the Context”. In this context, […]

11 December, 2023

8,000 women in Greece avoided chemotherapy thanks to Oncotype DX®

Approximately 8,000 women with early breast cancer in Greece were able to avoid chemotherapy thanks to Oncotype DX®’s decision guidance This year marks 15 years since the introduction of the […]

18 October, 2023

RediScore: Prospective validation of a pipeline for homologous recombination deficiency analysis

The study by the Genekor Scientific Team, titled “RediScore: Prospective Validation of a Pipeline for Homologous Recombination Deficiency Analysis,” was published in Oncology Letters The study by the Genekor Scientific […]

19 September, 2023

prime DX: A New Era in Personalized Cancer Treatment!

prime DXThe prime DX assay provides a detailed blueprint of tumor biology, which is used by the physician to design the most effective individualized treatment plan for the patient.It includes […]

26 July, 2023

W4O Hellas & ARTE in collaboration with Genekor Medical S.A give women the opportunity to do a Free Genetic Test for hereditary predisposition to breast-ovarian cancer.

W4O Hellas & ARTE in collaboration with Genekor Medical S.A give women the opportunity to do a Free Genetic Test for hereditary predisposition to breast-ovarian cancer. The company Genekor actively […]